No Data
Shanghai Haoyuan Chemexpress Co., Ltd.'s (SHSE:688131) Stock Is Rallying But Financials Look Ambiguous: Will The Momentum Continue?
Haoyuan Pharmaceutical: Summary of the 2024 Annual Report of Shanghai Haoyuan Pharmaceutical Co., Ltd.
Haoyuan Pharmaceutical: 2024 Annual Report of Shanghai Haoyuan Pharmaceutical Co., Ltd.
Shanghai Haoyuan Pharmaceutical Co., Ltd. 2024 Annual Report
Summary of the 2024 Annual Report of Shanghai Haoyuan Pharmaceutical Co., Ltd.
GTJA: Continuous iteration of anti-tumor therapies, domestic new drugs welcome breakthroughs.
GTJA focuses on products with significant differentiation advantages and leading companies in innovative segments.
Shanghai Haoyuan Chemexpress Co., Ltd.'s (SHSE:688131) P/E Is Still On The Mark Following 31% Share Price Bounce
